AbbVie's experimental drug to treat early Parkinson's disease helped significantly improve patients' ability to carry out ...

Tavapadon aims to treat Parkinson’s motor symptoms by mimicking dopamine in a once-a-day oral dose. And the pivotal, ...

AbbVie's experimental drug to treat early Parkinson's disease met the main goal in a late-stage study, the drugmaker said on ...

Intra-Cellular Therapies is developing Lenrispodun for the treatment of patients with Parkinson's Disease in a phase 2 study.

Philip Stevens, a 66 year old from Hampshire, has received £70,000 from his GP following a lawsuit after he was given the ...

A decline in motor skills is a hallmark of Parkinson's disease, regularly taking the form of slowness, rigidity, and tremors.

A new study has revealed that the widely prescribed Parkinson's disease drug entacapone significantly disrupts the human gut microbiome by inducing iron deficiency. The research was conducted ...

Sep. 24, 2024 — Parkinson's disease, a debilitating nervous system disorder, is treated with medications that sometimes cause impaired decision-making and poor ... Some Diabetes Drugs Tied to ...

Data from a late-stage study shows that treatment with flexible doses of ABBV's tavapadon reduced the burden of Parkinson's ...

Hello from San Diego, where I always happen to be, but where this weekend I had the delight of hanging out with coworkers ...

University of Southern California-led researchers have discovered the structural details of a brain receptor called GPR6, ...